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Abstract
Prions propagate as multiple strains in a wide variety of mammalian species. The detection
of all such strains by a single ultrasensitive assay such as Real Time Quaking-induced Con-
version (RT-QuIC) would facilitate prion disease diagnosis, surveillance and research. Pre-
vious studies have shown that bank voles, and transgenic mice expressing bank vole prion
protein, are susceptible to most, if not all, types of prions. Here we show that bacterially
expressed recombinant bank vole prion protein (residues 23-230) is an effective substrate
for the sensitive RT-QuIC detection of all of the different prion types that we have tested so
far – a total of 28 from humans, cattle, sheep, cervids and rodents, including several that
have previously been undetectable by RT-QuIC or Protein Misfolding Cyclic Amplification.
Furthermore, comparison of the relative abilities of different prions to seed positive RT-
QuIC reactions with bank vole and not other recombinant prion proteins allowed discrimina-
tion of prion strains such as classical and atypical L-type bovine spongiform encephalopa-
thy, classical and atypical Nor98 scrapie in sheep, and sporadic and variant Creutzfeldt-
Jakob disease in humans. Comparison of protease-resistant RT-QuIC conversion products
also aided strain discrimination and suggested the existence of several distinct classes of
prion templates among the many strains tested.
Author Summary
Prion diseases are neurodegenerative disorders that propagate as multiple strains in a vari-
ety of mammalian species. The detection of all such prion types by a single ultrasensitive
assay, such as the Real Time Quaking-induced Conversion (RT-QuIC) assay, would facili-
tate prion disease diagnosis, surveillance, and research. Here we show detection of minute
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amounts of 28 different prion types from humans, cattle, sheep, cervids and rodents, some
of which were previously undetectable, using a single recombinant bank vole prion protein
substrate. We also demonstrate the generation of prion type-dependent RT-QuIC conver-
sion products which may help with prion strain discrimination and the characterization of
distinct classes of prion templates. Finally, we describe a practical strategy for prion strain
discrimination, e.g. classical and atypical L-type bovine spongiform encephalopathy; clas-
sical and atypical Nor98 sheep scrapie; and human sporadic and variant Creutzfeldt-Jakob
disease. Thus, our study provides a basis for wide-ranging prion detection and strain
discrimination.
Introduction
Prion diseases, or transmissible spongiform encephalopathies, are neurodegenerative disorders
that include Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler-Scheincker syndrome
(GSS), fatal familial insomnia (FFI) and sporadic fatal insomnia (sFI) in humans, bovine spon-
giform encephalopathy (BSE) in cattle, scrapie in sheep, and chronic wasting disease (CWD) in
cervids. The origin of prion diseases can be infectious, genetic or sporadic. Many prion diseases
also have subtypes or strains that can be distinguished based on the PRNP (prion protein)
genotype, transmission characteristics, clinical manifestations, neuropathological lesion pro-
files and/or biochemical properties of the disease-associated forms of prion protein (PrPD) [1–
9]. PrPD, or a subset thereof, is the predominant molecular component of the infectious agent,
or prion, which propagates itself by inducing misfolding of the hosts’ normal protease-sensitive
prion protein, PrPC or PrPSen, into additional PrPD. This propagation mechanism appears to
involve seeded, or templated, polymerization in which the given PrPD conformation is imposed
upon normally monomeric PrPSen molecules as they are recruited into growing PrPD multi-
mers [3,4].
PrPD usually includes forms called PrPRes that, unlike the normal PrPSen, are partially resis-
tant to digestion by proteinase K (PK). The banding pattern of PrPRes in immunoblots can vary
distinctively depending on the prion strain, host species and/or PRNP genotype. With most
prion diseases the predominant 21-32-kDa variably glycosylated PrPRes fragments observed on
immunoblots extend from ragged N-termini between residues ~80–96 to the GPI-anchored C-
terminus (e.g., at residue 231 in humans). In contrast, the PrPRes associated with sheep Nor98
scrapie and human GSS linked to the P102L, F198S, A117V and H187R PRNPmutations
include much smaller 6–14 kDa bands [10–12]. These bands are internal fragments with rag-
ged N-and C-termini within residues ~80-~160 [13]. In cases of P102L GSS, brain tissue from
some individuals can also give 21–32 kDa PrPRes bands with the 7–8 kDa bands, while others
give the 21–32 kDa PrPRes bands but lack the 7–8 kDa bands. Hereafter, we will refer to the for-
mer cases as GSS P102L and the latter as GSS P102L.
A major challenge for the prion disease field is the development of sufficiently practical and
sensitive tests for routine prion disease detection and strain discrimination in medicine, agri-
culture, wildlife management and research. The Real Time Quaking Induced Conversion
(RT-QuIC) assay, which is based on prion-seeded fibrillization of recombinant prion protein
(rPrPSen), is known to be highly specific and ultra-sensitive for detection of multiple human
and animal prion diseases [14–20]. Moreover, like the amyloid seeding assay [21], RT-QuIC is
more practical than comparably ultra-sensitive assays by being relatively rapid and based on a
96-well plate format with fluorescence readout [14,16]. Appropriate combinations of prion
type and rPrPSen substrate have been important in the performance of various RT-QuIC assays
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[14,18–20,22–25]. For several types of prion disease, however, no effective rPrPSen substrate
has been identified; these types include human GSS arising from P102L, F198S, A117V and
H187R PRNPmutations and the atypical sheep scrapie strain Nor98. Moreover, no single sub-
strate has yet been shown to detect all of the different prion variants of humans, cattle, sheep,
cervids and rodents.
One potential rPrPSen substrate that has not been described for RT-QuIC assays is based on
the bank vole sequence. Bank voles [26], and transgenic mice that express bank vole (BV)
PrPSen [27], are susceptible to an unusually wide range of prion strains from different species.
Furthermore, PrPSen in bank vole brain tissue homogenates is a broadly reactive, but not uni-
versal, substrate for the highly sensitive protein misfolding cyclic amplification (PMCA) assay
for prions [28]. Here we have tested the suitability of recombinant bank vole PrPSen (BV
rPrPSen), when expressed in E. coli and purified, as an RT-QuIC substrate. We have found so
far that BV rPrPSen is a universally effective substrate for multiple prion strains from multiple
species, and, most notably, for prions for which no effective substrate has been available. Fur-
thermore, we have found that BV rPrPSen-based RT-QuIC reactions give strain-dependent PK-
resistant products in a manner that should further facilitate prion strain discrimination.
Results
Lack of detection of GSS and atypical scrapie subtypes associated with
6–14 kDa PrPRes fragments using previously described rPrPSen
constructs
Most mammalian PrPRes types with predominant 21–32 kDa PrPRes bands can seed Thioflavin
T-positive (ThT) amyloid formation in RT-QuIC reactions [17,22,29–32] using at least one of
the following substrates: Syrian golden hamster rPrPSen residues 90–231 [14,30,31], Syrian
golden hamster rPrPSen 23–231 [18], human rPrPSen 23–231 [16], murine rPrPSen 23–231 [24]
or hamster-sheep chimeric rPrPSen 23–231 [19,22]. For example, detection of human P102L
GSS brain tissue using hamster rPrPSen 90–231 is shown in Fig 1. However, to date, no detec-
tion of RT-QuIC seeding activity has been reported using these rPrPSen substrates with cases of
human GSS or sheep scrapie that give prominent low molecular weight PrPRes fragments in
immunoblots, despite extensive efforts. Specifically, these cases include human GSS with the
F198S, A117V or H187R mutations and sheep Nor98 scrapie types giving 6–14 kDa PrPRes
fragments [10–13], and the human P102L-GSS with an ~8 kDa PrPRes fragment (P102L) [10].
Our inability to detect these prion types is exemplified in Fig 1 using 10-3 brain tissue dilutions
of human GSS F198S and P102L and sheep Nor98 scrapie with the hamster rPrPSen 90–231.
In contrast, P102L GSS (without the ~8-kDa fragment) gave positive reactions with
1,000,000-fold smaller amounts of brain tissue.
Detection of GSS F198S and A117V prion seeding activity using BV
rPrPSen
We then tested bank vole rPrPSen residues 23–230 (BV rPrPSen) as a substrate to detect seeding
activity of two human prion subtypes that have not been detectable previously by RT-QuIC,
namely F198S- and A117V-GSS. Concurrently, we varied two parameters that we have shown
to be influential, namely the concentrations of NaCl [14] and Sodium Dodecyl Sulfate (SDS)
[30]. Each reaction was seeded with 10-4 dilutions of frontal cortex brain tissue from confirmed
GSS cases carrying either the F198S or A117V mutation of the prion protein gene. We found
that our standard concentrations of SDS (0.002%) in combination with either 130 or 300mM
NaCl failed to allow a distinction in lag phase between prion positive and uninfected brain
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homogenate (BH) seeded reactions (Fig 2A and 2B). Lowering the SDS concentration to
0.001% with either 130 or 300mMNaCl improved this distinction between prion positive and
uninfected BH seeded reactions (Fig 2C and 2D). However, using final concentrations of 300
mMNaCl and 0.001% SDS, provided much shorter lag phases in reactions seeded with the two
GSS subtypes than with the cerebral ischemia negative control (Fig 2D). These results indicated
that under these latter RT-QuIC conditions BV rPrPSen detected seeding activity associated
with PrPD conformers that had not otherwise been detectable by RT-QuIC or PMCA prion
seed amplification techniques [33].
Next, we assessed the sensitivity of this new RT-QuIC assay for detecting GSS-associated
prion seeding activity. Reactions were seeded with 10-4 to 10-9 dilutions of brain tissue from
GSS patients carrying the P102L, P102L, A117V, F198S and H187R mutation of the prion
gene (Fig 3A–3E). A reaction time cutoff of 50h was chosen because in more than 20 indepen-
dent RT-QuIC experiments seeded with negative control Alzheimer’s disease (AD) or cerebral
ischemia brain homogenates, no positive RT-QuIC reactions were observed until after 55h (in
rare wells). We detected GSS P102L, P102L, A117V and F198S and H187R prion seeding
activity in as little as 10-9, 10-4, 10-8, 10-8 and 10-6 dilutions of brain (frontal cortex) tissue dilu-
tions, respectively (Fig 3).
Detection of 28 different prion types/strains of human, sheep, cattle,
deer, elk, mouse and hamster using BV rPrPSen
After finding that BV rPrPSen supported RT-QuIC detection of prion seeding activity from pre-
viously undetectable types of GSS, we tested whether BV rPrPSen could be used to detect other
types of prion diseases. We tested 28 different types of prions in brain tissue from humans,
sheep, mouse, hamster, cattle, elk, and deer (Tables 1 and 2) and found that all of them gave
faster and stronger positive ThT fluorescence responses than a variety of uninfected negative
control brain specimens (Fig 4). Among the 28 were the five prion types that have not been
detectable by RT-QuIC under other conditions, namely human GSS F198S, A117V, H187R,
Fig 1. RT-QuIC detection of GSS P102L and lack of detection for GSS F198S, P102L* and sheep
atypical Nor98 scrapie using hamster rPrPSen 90–231. Serial dilutions (10-6 to 10-9) of GSS P102L brain
tissue dilutions were used to seed quadruplicate RT-QuIC reactions (red lines) with hamster 90–231 rPrPSen
as the substrate, 300mMNaCl, 0.002% SDS. The same rPrPSen and RT-QuIC conditions listed above were
used in reactions seeded with the designated brain tissue dilutions of GSS human patients with F198S (green
line) or P102L* (gray line) PRNP point mutations, Alzheimer’s disease (AD, blue line), sheep without prion
disease (blue line) or with Nor98 scrapie (orange line). Average ThT fluorescence readings from replicate
wells for each type of sample were plotted as a function of time. Results are representative of similar findings
from at least 10 independent experiments using hamster 90–231, hamster 23–231, human or hamster-sheep
chimeric rPrPSen substrates.
doi:10.1371/journal.ppat.1004983.g001
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and P102L and sheep Nor98 scrapie (Fig 4, red traces). These results indicated that under
these conditions, BV rPrPSen is the most broadly prion-seeded RT-QuIC substrate described to
date.
Prion strain/type-dependent RT-QuIC products from reactions using BV
rPrPSen
Prion strain-dependence has not been observed previously in the immunoblot banding profile
of PK-treated recombinant PrPRes (rPrPRes) products of RT-QuIC reactions. However, using
BV rPrPSen we observed consistently distinct products of RT-QuIC reactions seeded with dif-
ferent types of human prions (Fig 5 and Table 1). The observed banding patterns could be
grouped based on the type of seed: GSS cases (F198S, A117V, H187R) with the ~8–14 Kda pro-
tease-resistant bands and sFI gave 2 bands: a major ~10kDa band and a ~6-9kDa band; the
GSS (P102L), gCJD (E200K, V210I, six octarepeat insertion), and the iatrogenic CJD (iCJD)
cases with ~21–32 kDa PrPRes bands gave multiple bands with a major ~12 Kda band and mul-
tiple minor bands between ~6–10 kDa; variant CJD, GSS (P102L) and FFI (D178N) cases
gave a single predominant band at ~10 kDa; and sporadic CJD in some cases gave two bands
Fig 2. Detection of GSS P102L, F198S and A117V PrPD types by RT-QuIC using BV rPrPSen, 300mMNaCl and 0.001% SDS.Quadruplicate RT-QuIC
reactions were seeded with 10-4 dilutions of human frontal cortex brain tissue from GSS patients with the P102L (red lines), F198S (green lines), or A117V
(magenta lines) PRNPmutation. Negative control reaction were seeded with 10-4 dilutions of frontal cortex brain tissue from a cerebral ischemia patient (blue
lines). A final SDS concentration of 0.002% (A and B) or 0.001% (C and D) in combination with 130 mM (A and C) or 300 mM (B and D) NaCl were used with
BV rPrPSen. Similar results were seen in three independent experiments. Traces from representative RT-QuIC experiments are the average of four replicate
wells.
doi:10.1371/journal.ppat.1004983.g002
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between ~10–12 kDa, while in other cases gave a predominant band at ~ 10 kDa. Repeated
analyses (>4) of individual sCJD cases indicated that they consistently seeded the formation of
only one or the other of the latter two rPrPRes products. This observation provided evidence
that the different sCJD-seeded rPrPRes products were dictated by differential templating activ-
ity in the tissue samples rather than stochastic events during the RT-QuIC reaction. Addition-
ally, because these immunoblots used an antiserum to the C-terminus of PrP, the fragments
likely differed primarily at their N-termini.
We further compared the BV rPrPRes products of reactions seeded with different rodent,
bovine, cervine and ovine prion strains (Table 2). As with the human prion seeds, we observed
distinct strain-dependent BV rPrPRes banding profiles from reactions seeded with different
prion types. Mouse 22L scrapie-seeded BV rPrPRes products consistently showed a ~10 and
~12 kDa PK-resistant band, whereas BV rPrPRes products from reactions seeded with
Fig 3. RT-QuIC sensitivity for detection of human GSS P102L, P102L*, A117V, F198S, and H187R seeding activity using BV rPrPSen. The designated
dilutions of frontal cortex brain tissue from the designated GSS P102L (A), P102L* (B), A117V (C), F198S (D), and H187R (E) patients were used to seed
RT-QuIC reactions with 0.001% SDS and 300mMNaCl. Negative control reactions were seeded with Alzheimer’s disease (AD) brain tissue (A-E, blue lines).
Representative data from one of three independent experiments is shown as the averages of fluorescence values from four replicate wells.
doi:10.1371/journal.ppat.1004983.g003
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Fig 4. RT-QuIC detection of 28 types of prion seeds from 5 different species using new BV rPrPSen substrate.RT-QuIC reactions were seeded with
10-4 brain tissue dilutions of the indicated human and animal prion types in the presence of 300mMNaCl and 0.001% SDS. Equivalent dilutions of species-
and brain region-matched samples from uninfected individuals were used as specificity controls (green). Prion types that have been detected previously by
RT-QuIC using other substrate are indicated in black, whereas those that have only been detectable using our selected set of conditions and BV PrPSen are
indicated in red. The traces show the average fluorescence from four replicate wells. Similar data were obtained from a minimum of three independent
experiments with each prion type.
doi:10.1371/journal.ppat.1004983.g004
Fig 5. Western blot of BV rPrPRes products from RT-QuIC reactions seeded with various human prion types. Reaction products were digested with
10μg/mL of PK. Immunoblots were probed with the C-terminal antibody R20 (hamster PrP epitope residues 218–231). Molecular mass (MM) is indicated in
kilodaltons. Immunoblots are representative of one biological replicate (n = total biological replicates tested) each giving rPrPRes banding profiles similar to
that/those shown. (#) Samples for which cerebellum, frontal cortex, basal ganglia and thalamus from the same patient were analyzed. A minimum of two sets
of RT-QuIC bank vole rPrPRes products were generated from a given prion type and independently subjected to immunoblotting analysis.
doi:10.1371/journal.ppat.1004983.g005
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Table 1. Human samples: diagnosis, PRNP genotype and brain regions.
Species Diagnosis Genotype Brain Region Detectable Dilution+
Human Alzheimer's Disease NA Frontal Cortex no reaction at 10-4
Alzheimer's Disease NA Frontal Cortex no reaction at 10-4
Parkinson's Disease NA Frontal Cortex no reaction at 10-4
Cerebral Ischemia NA Frontal Cortex no reaction at 10-4
Tumor NA Frontal Cortex no reaction at 10-4
sCJD1 Type 1 129MM Frontal Cortex 10-8
sCJD Type 1 129VV Frontal Cortex
sCJD Type 1 129MM Frontal Cortex
sCJD Type 2 129MM Frontal Cortex
sCJD Type 2 129VV Frontal Cortex
sCJD Type 2 129MM Frontal Cortex
vCJD2 NA NA 10-7
vCJD NA NA
vCJD NA NA
iCJD3 Type 1 129MM Frontal Cortex ‡
iCJD Type 1 129MM Frontal Cortex
iCJD Type 1 129MM Frontal Cortex
iCJD Type 1 129MM Frontal Cortex
iCJD Type 1 129MM Frontal Cortex
iCJD Type 1 129MV Frontal Cortex
iCJD Type 2 129MV Frontal Cortex
iCJD Type 2 129VV Frontal Cortex
E200K-gCJD4 129MM Frontal Cortex
E200K-gCJD 129MM Frontal Cortex
V210I-gCJD 129MM Cerebellum #
V210I-gCJD 129MM Frontal Cortex
V210I-gCJD 129MM Basal Ganglia
V210I-gCJD 129MM Thalamus
Six Octarepeat Insert-gCJD 129VV Cerebellum #
Six Octarepeat Insert-gCJD 129VV Frontal Cortex
Six Octarepeat Insert-gCJD 129VV Basal Ganglia
Six Octarepeat Insert-gCJD 129VV Thalamus
F198S GSS5 129MV Frontal Cortex 10-8
F198S-GSS 129VV Frontal Cortex
F198S-GSS 129MV Frontal Cortex
H187R-GSS 129MV Frontal Cortex 10-6
H187R-GSS 129MV Frontal Cortex
A117V-GSS 129VV Frontal Cortex 10-8
A117V-GSS 129VV Frontal Cortex
P102L*-GSS 129MV Frontal Cortex 10-4
P102L-GSS 129MV Frontal Cortex
P102L-GSS 129MM Frontal Cortex 10-9
(Continued)
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Chandler, ME7, 87V and anchorless 22L (22L GPI-) scrapie displayed a predominant ~10 kDa
band (Fig 6A). The lack of the GPI anchor in the 22L GPI- scrapie seed resulted in an RT-QuIC
product that was distinct from the wild-type GPI-anchored 22L scrapie. Additionally, closely
related hamster prion strains (Hyper and 263K; Fig 6B) showed similar BV rPrPRes banding
profiles (~10 and ~12 kDa PK-resistant bands) which were distinct from the Drowsy-seeded BV
rPrPRes products (primarily a ~10 kDa band; Fig 6B). Deer and elk CWD-seeded reactions each
gave ~8, 9, 10, and 12 kDa bands, but differed in the relative intensities of the top two bands
between the two (Fig 6C). Furthermore, distinct strain-dependent BV rPrPRes banding profiles
were observed between classical (C-BSE) and atypical (L-BSE) (~10 kDa vs. ~9, 10, and 12 kDa
bands, respectively; Fig 6C), as well as between classical and atypical Nor98 sheep scrapie (~10
kDa vs. ~9, 10, and 12 kDa bands, respectively; Fig 6D). Collectively, these immunoblotting
results suggested that certain human and animal prion diseases can be discriminated in part
based on analysis of the rPrPRes products of BV rPrPSen-based RT-QuIC reactions.
Detection and discrimination of classical and atypical BSE using BV and
hamster rPrPSen substrates
We previously reported that classical and atypical L-type BSE strains can be discriminated on
the basis of relative RT-QuIC reactivities with hamster rPrPSen 90–231 and hamster-sheep chi-
meric rPrPSen 23–231 substrates [22]. Here we found that BV rPrPSen can similarly detect both
classical and L-type BSE, providing an alternative substrate for discrimination between the two
bovine strains. Specifically, detection of seeding activity with BV rPrPSen (Fig 7) but not with
three other rPrPSen substrates that detected only L-type BSE, namely human 23–231, hamster
23–231 or hamster 90–231 [22], can be used to differentiate these two bovine prion types.
Discrimination of classical and Nor98 sheep scrapie using BV and
hamster-sheep chimeric rPrPSen substrates
Having detected Nor98 sheep scrapie with BV rPrPSen, (Fig 4) we tested whether a strategy sim-
ilar to the one described above for C- vs. L-type BSE using different rPrPSen substrates would
Table 1. (Continued)
Species Diagnosis Genotype Brain Region Detectable Dilution+
P102L-GSS 129MM Frontal Cortex
D178N -FFI6 129MM Frontal Cortex
D178N -FFI 129MM Frontal Cortex
sFI7 129VV Frontal Cortex
Diagnosis, genotype and brain regions for human samples
1 Sporadic Creutzfeldt-Jakob disease
2 Variant Creutzfeldt-Jakob disease
3 Iatrogenic Creutzfeldt-Jakob disease
4 Genetic Creutzfeldt-Jakob disease
5 Gerstmann–Sträussler–Scheinker syndrome
6 Fatal familial insomnia
7 Sporadic fatal insomnia
‡ All French cases for which the source of prion contamination were growth hormone (7 patients) and dura matter graft (1 patient)
#Samples from the same patient
+Only dilutions of samples that were tested to end-point are displayed. Unless indicated all samples were tested at 10-4 tissue dilutions.
doi:10.1371/journal.ppat.1004983.t001
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Table 2. Animal samples: prion disease, Prnp genotype and brain region.
Species Prion Disease Genotype Brain Region Detectable Dilution+
Rodent Chandler Mouse NA Whole Brain
Chandler Mouse NA Whole Brain
22L Mouse NA Whole Brain
22L Mouse NA Whole Brain
22L GPI- Mouse NA Whole Brain
22L GPI- Mouse NA Whole Brain
ME7 Mouse NA Whole Brain
ME7 Mouse NA Whole Brain
87V Mouse NA Whole Brain
87V Mouse NA Whole Brain
Uninfected Mouse NA Whole Brain no reaction at 10-4
Uninfected Mouse NA Whole Brain no reaction at 10-4
Hyper Hamster NA Whole Brain
Hyper Hamster NA Whole Brain
Drowsy Hamster NA Whole Brain
Drowsy Hamster NA Whole Brain
263K Hamster NA Whole Brain
263K Hamster NA Whole Brain
Uninfected Hamster NA Whole Brain no reaction at 10-4
Uninfected Hamster NA Whole Brain no reaction at 10-4
Bovine L-BSE NA Brain Stem
L-BSE NA Brain Stem
C-BSE NA Frontal Cortex
C-BSE NA Frontal Cortex
Uninfected Bovine NA Brain Stem no reaction at 10-4
Uninfected Bovine NA Brain Stem no reaction at 10-4
Cervid CWD1 Elk NA Brain Stem
CWD Elk NA Brain Pool
Uninfected Elk NA Brain Stem no reaction at 10-4
CWD Deer NA Brain Pool
CWD Deer NA Cortex
CWD Deer NA Cortex
Uninfected Deer NA Brain Pool no reaction at 10-4
Uninfected Deer NA Cortex no reaction at 10-4
Ovine Classical Scrapie VRQ/VRQ† Cerebellum 10-6
Classical Scrapie ARQ/ARQ Cerebellum
Classical Scrapie ARQ/ARQ Cerebellum
Classical Scrapie ARQ/ARQ Cerebellum
Classical Scrapie ARQ/ARQ Cerebellum
Classical Scrapie ARQ/ARQ Cerebellum
Classical Scrapie VRQ/VRQ Cerebellum
Classical Scrapie ARQ/ARQ Cerebellum
Nor98 Atypical Scrapie ARR/AHQ† Cerebellum 10-7
Nor98 Atypical Scrapie ARQ/ARQ Cerebral Cortex
(Continued)
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allow discrimination of Nor98 and classical sheep scrapie. Brain tissue from eight sheep with
classical scrapie [ARQ/ARQ (n = 6), VRQ/VRQ (n = 2) PrP genotypes, Table 2] were readily
detected using the hamster-sheep chimeric rPrPSen 23–231 within ~40hs (Fig 8A). However,
brain tissue from eight cases of Nor98 scrapie [ARR/AHQ (n = 1), ARQ/ARQ (n = 4), ARQ/
AHQ (n = 2) and ARR/ARR (n = 1) genotypes, Table 2] gave no positive responses using the
same substrate (Fig 8B). In contrast, consistent with the results in Fig 4, seven of these cases
gave positive responses when BV rPrPSen was used in reactions seeded with 10-4 brain tissue
dilutions (Fig 8A–8E, orange lines) and those that were weaker or not detected were positive
when seeded with 10-3 dilutions (Fig 8A–8E, red lines). To compare the sensitivities of the
assay for detection of classical and atypical scrapie using these two substrates, we diluted repre-
sentative brain homogenates from classical and Nor98 scrapie positive sheep (Fig 8G–8J) and
tested them using both BV and Ha-S rPrPSen. We detected classical scrapie down to 10-8 dilu-
tions using Ha-S rPrPSen and down to 10-6 using BV rPrPSen. Consistent with the data in Fig 8,
no fluorescence increases were seen in reactions seeded with the same dilutions of a Nor98
atypical scrapie sample when using Ha-S rPrPSen. In contrast, parallel reactions with BV
rPrPSen gave positive reactions when seeded with Nor98 brain dilutions down to 10-6–10-7,
indicating that BV rPrPSen is ~1,000-fold more sensitive at detecting Nor98 scrapie than is Ha-
S rPrPSen. Collectively, these results suggest that if an ovine brain sample gives a positive
RT-QuIC response with BV rPrPSen, it should give a stronger positive reaction with Ha-S
rPrPSen if it contains classical scrapie, but a negative, or at least much weaker, reaction if it con-
tains Nor98 scrapie.
Detection and discrimination of human sCJD and vCJD using BV and
hamster 23–231 rPrPSen substrates
To investigate the discrimination of two non-genetic human prion strains, we tested 10-4 brain
tissue dilutions from two confirmed cases of Type 1 sCJD (Fig 9A and 9B, Cases a and b, green
lines) and two cases of vCJD (Fig 9A and 9B, Cases c and d, orange lines). We used previously
described SDS conditions (0.002% final concentration of SDS; [23]) with hamster 23–231
rPrPSen, and 0.001% SDS with BV rPrPSen, both in the presence of 300mMNaCl. We observed
rapid amplification of prion seeding activity in the two Type 1 sCJD samples when using either
hamster 23–231 or BV rPrPSen (Fig 9A and 9B). Our detection of the sCJD samples with the
Table 2. (Continued)
Species Prion Disease Genotype Brain Region Detectable Dilution+
Nor98 Atypical Scrapie ARQ/ARQ Cerebellum
Nor98 Atypical Scrapie ARQ/ARQ Cerebellum
Nor98 Atypical Scrapie ARQ/ARQ Cerebellum
Nor98 Atypical Scrapie ARQ/AHQ Cerebellum 10-3
Nor98 Atypical Scrapie ARQ/AHQ Cerebellum
Nor98 Atypical Scrapie ARR/ARR Cerebellum
Uninfected Sheep ARQ/ARQ† Cerebellum no reaction at 10-4
Uninfected Sheep ARQ/ARQ Cerebellum no reaction at 10-4
Prion disease, Prnp genotype and brain region for animal samples.
† Sheep Prnp genotype at codons 136/154/171
+Only dilutions of samples that were tested to end-point are displayed. Unless indicated all samples were tested at 10-4 brain tissue dilutions.
1Chronic Wasting Disease
doi:10.1371/journal.ppat.1004983.t002
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Fig 6. Western blot of BV rPrPRes from RT-QuIC reactions seeded with rodent, bovine, cervine and
sheep prion types. PK-treated RT-QuIC products frommouse (A), hamster (B), cattle (C), deer (C), elk (C)
and sheep (D) prion seeds were probed with R20 (hamster PrP epitope residues 218–231). In (D), the
classical scrapie-seeded reactions include those seeded with samples from PRNP VRQ/VRQ and ARQ/ARQ
sheep (not designated). The Nor98-seeded reactions were seeded with samples from ARR/ARR, ARQ/AHQ
and ARQ/ARQ sheep. RT-QuIC reactions and immunoblotting analysis for each of these types of prions were
performed at least twice with similar results. The banding profiles shown are representative of multiple (n)
independently tested biological replicates.
doi:10.1371/journal.ppat.1004983.g006
Fig 7. Detection of Classical (C-BSE) and atypical (L-type BSE) with BV rPrPSen substrate.RT-QuIC
reactions were seeded with 10-4 brain tissue dilutions of brain stem (C-BSE, blue) or frontal cortex (L type-
BSE, magenta) from Italian cattle. Negative control reactions (NBH, green) were seeded with 10-4 dilutions of
frontal cortex or brain stem from uninfected cattle. BV rPrPSen was used as a substrate with 300mMNaCl and
0.001% SDS. RT-QuIC analysis was performed at least twice for each sample with similar results. Results
are plotted as the averages from four replicate wells.
doi:10.1371/journal.ppat.1004983.g007
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Fig 8. Detection, discrimination and sensitivities for detection of classical and Nor98 sheep scrapie with BV and Ha-S rPrPSen substrates.RT-QuIC
reactions were seeded with dilutions of cerebellum or cerebral cortex from uninfected, classical or Nor98 atypical scrapie positive sheep. The Nor98 (ARR/
AHQ, ARQ/ARQ, ARQ/AHQ and ARR/ARR PRNP genotypes) reactions were seeded with 10-4 (orange) brain tissue dilutions. Additional 10-3 (red) brain
tissue dilutions are also shown for weaker samples. Classical sheep scrapie brain tissue from eight animals (ARQ/ARQ, VRQ/VRQ PRNP genotypes) was
diluted 10-4 (green, A and D). Equivalent dilutions of cerebellum or frontal cortex brain tissue dilutions (ARQ/ARQ PRNP genotypes) were used as specificity
controls (blue, C and F). Either Ha-S rPrPSen (300mMNaCl and 0.002% SDS; A-C) or BV rPrPSen (300mMNaCl and 0.001% SDS; D-F) were used as
substrates. Brain homogenates from classical scrapie positive sheep (green, VRQ/VRQ) and atypical Nor98 scrapie positive sheep (orange, ARR/AHQ)
were serially diluted (10-4 to 10-8) for RT-QuIC analysis using Ha-S rPrPSen with 300mMNaCl and 0.002% SDS (G and H) or BV rPrPSen with 300mMNaCl
and 0.001% SDS (I and J) substrates. RT-QuIC testing was performed independently twice with similar results. Traces show averages of quadruplicate wells.
doi:10.1371/journal.ppat.1004983.g008
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hamster 23–231 substrate was consistent with previous demonstrations that all sCJD subtypes
are detectable with this substrate [23,30,34]. No increase in ThT fluorescence was seen in
vCJD-seeded hamster 23–231 rPrPSen RT-QuIC reactions (Fig 9A). However, in accordance
with the results shown in Fig 4, seeding activity was detected in both vCJD samples using BV
rPrPSen (Fig 9B). Thus, sporadic and variant CJD sample were discriminated by differential
reactivities with the BV and hamster 23–231 rPrPSen substrates.
Next we compared the RT-QuIC sensitivities for detection of sCJD and vCJD brain
homogenates using hamster and BV rPrPSen. We performed end-point dilution RT-QuIC
analysis of brain tissue from sCJD (Case a) and vCJD (Case c) (Fig 9C–9F, green and orange
lines, respectively). We detected sCJD down to 10-8/10-9 with hamster 23–231 rPrPSen, (Fig
9C) and 10-8 with BV rPrPSen (Fig 9D). Although sCJD gave slightly slower amplification
kinetics with hamster 23–231 rPrPSen (Fig 9C) compared to BV rPrPSen (Fig 9D), the overall
sensitivities using the two substrates were comparable. In contrast, markedly different sensi-
tivities were observed with the two substrates in the vCJD-seeded reactions. Specifically, only
weak seeding activity was occasionally detected in 10-4 or 10-5 brain dilutions with hamster
23–231 rPrPSen (representative data in Fig 9E), but fast and sensitive detection of vCJD seed-
ing activity down to 10-7 brain tissue dilution was observed using BV rPrPSen (Fig 9F). These
results suggest that BV rPrPSen is 100–10,000-fold more sensitive than hamster 23–231
rPrPSen in detecting vCJD brain derived prion seeding activity. Collectively, these findings fur-
ther support the potential broad applicability of a BV rPrPSen prion discrimination strategy to
a variety of prion types.
Fig 9. Detection, discrimination and sensitivities for detection of human sCJD and vCJDwith hamster 23–231 and BV rPrPSen substrates. Dilutions
(10-4) of frontal cortex brain tissue from two confirmed sCJD (Case a and b, green) and two vCJD cases (Case c and d, orange) were used to seed RT-QuIC
reactions. Testing was performed using either hamster (23–231) in the presence of 300mMNaCl and 0.002% SDS (A) or BV PrPSen in the presence of
300mMNaCl and 0.001%SDS (B). Brain homogenates from one sCJD (Case a) and one vCJD (Case c) patient were serially diluted (10-5 to 10-8) for
RT-QuIC analysis. Hamster 23–231 (C and E) and BV rPrPSen (D and F) were used as a substrate. These samples were tested in three independent
experiments with similar results. Traces represent the averages of four replicate wells.
doi:10.1371/journal.ppat.1004983.g009
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Discussion
The lack of practical and cost-effective tests that are sensitive enough to detect the lowest infec-
tious levels of prions has long been a major impediment in coping with prion diseases. Rapid
commercially available immunoassays have allowed post-mortem detection of prion infections
in high-titered tissues such as brain or lymphoid tissues, but diagnostic specimens that are
most readily accessible in living hosts, such as blood, CSF and nasal brushings, have much
lower prion titers that are undetectable with these assays. In contrast, RT-QuIC assays have
been highly effective in detecting prion seeding activity in such low-titered specimens, and are
being widely implemented as state-of-the-art diagnostic tests for humans and animals [16,18–
20,25,34–37]. Moreover, recent improvements have increased the speed and sensitivity of
RT-QuIC assays such that sCJD testing based on human CSF samples can now be performed
in a matter of hours rather than days [30].
In our experience, the most demanding and costly requirement for RT-QuIC testing is the
availability of suitable rPrPSen substrates. Prior to the present study, testing facilities would typ-
ically have to produce or procure multiple rPrPSen sequences to be able to test for multiple
prion types. However, we have now shown that all of the prion diseases that we have tested so
far from humans and other mammals can be detected sensitively by using BV rPrPSen (Fig 4).
This provides a useful platform for broad-based prion detection and strain discrimination.
Thus, we envision that most initial screening for the presence of a wide variety of prions could
be performed using BV rPrPSen. Once a prion-infected sample from a given host species is
identified, one could then often discriminate between strains by targeted use of another rPrPSen
substrate that is known to be differentially sensitive to seeding by prion strains of that host spe-
cies (Figs 7–9) and/or by performing immunoblots of the PK-resistant RT-QuIC products of
the reactions (Figs 5 and 6).
Although we have demonstrated detection of a wide variety of prion types, the relative sensi-
tivities of BV rPrPSen-based RT-QuIC for brain homogenates of hosts with different prion dis-
eases is presumably dependent on the concentrations of PrPD in the tissue samples. Clearly
PrPD concentrations may vary markedly between individuals and different regions of the brain
as a function of strain. Furthermore, because PrPD can vary markedly in its properties, e.g.
amyloid vs. non-amyloid, protease-sensitive vs. resistant, small vs. large particles, infectious vs.
non-infectious, it is probable that the RT-QuIC seeding activity will vary per unit PrPD
between different prion strains and tissue sources. Thus, although we have shown the potential
for BV rPrPSen-based RT-QuIC to detect and help discriminate prion strains, much additional
work with each type of prion and sample type will be required to better establish the quantita-
tive relationships between RT-QuIC seeding activity and the levels of various types of PrPD in
different tissues of diagnostic or scientific interest.
Since the inception of prion-seeded cell-free PrP conversion reactions [38], striking
sequence- and strain-specificities have been observed that appeared to correlate, at least largely,
with transmission barriers and strain phenotypes of prion diseases in vivo [3,39–41]. Indeed,
sequence differences of as little as a single residue between the PrPD seed and PrPSen substrate
can block PrPRes formation in such cell-free reactions [42], as it can in scrapie-infected cells
[43] and in vivo [44]. However, RT-QuIC assays have tended to be less constrained by such
sequence differences [14]. We reason that this is due in part to the fact that in RT-QuIC reac-
tions, it is only the C-terminal residues ~160–231 of the substrate molecules that must refold
into the PK-resistant amyloid core [45] to give a positive reaction, i.e., an increase in ThT fluo-
rescence. In contrast, earlier cell-free conversion [38,46,47] and PMCA reactions [48] have
used the immunoblot-based detection of much larger PK-resistant cores, typically comprised
of residues ~90–231, as a positive readout. Thus, much more extensive packing of more N-
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proximal residues is required in the latter reactions, as it is in vivo, giving more opportunities
for sequence differences between seed and substrate to influence conversion. Nonetheless,
despite the lower sequence specificity of RT-QuIC reactions, we and others have observed mul-
tiple examples of rPrPSen substrates that can be converted by some types of prion seeds and not
others [22,23]. Therefore, we were surprised to find that BV rPrPSen can be induced to convert
to ThT-positive amyloid by every type of prion-associated seed that we have tried so far
(n = 28), including several that had never before been detected by RT-QuIC or PMCA. We also
did not anticipate that different PK-resistant BV rPrPRes products of RT-QuIC reactions would
be seeded with different prion strains from a single host species, because we had never seen
such distinct templating with the many other rPrPSen substrates that we have tested. These
findings suggest that BV rPrPSen-based RT-QuIC reactions may provide a new means of prob-
ing the strain-dependent heterogeneity of prion seeding activities and conformational tem-
plates. However, overall, the RT-QuIC technology has been established largely for the practical
purposes of rapid, sensitive prion disease-associated seed detection rather than the in vitro
recapitulation of prion propagation. As such, the RT-QuIC tests have not been developed to
reflect prion transmission barriers or strain-specificities. In any case, the availability of BV
rPrPSen as an apparently universal RT-QuIC substrate may markedly improve the practicality,
efficiency and cost-effectiveness of detecting and discriminating prions.
Materials and Methods
Ethics statement
Brain tissue from scrapie-infected mice and hamsters (Table 2) were collected under Protocols
2013–030 and 2010–045, respectively, that were approved by the Rocky Mountain Laboratories
Animal Care and Use Committee. Human brain tissues (Table 1) were obtained from the
National Prion Disease Pathology Surveillance Center (USA). Brain tissue from humans with
vCJD (Table 1) was obtained from the National Institute for Biological Standards and Controls
(UK) repository. No human samples were collected expressly for this study, but were instead
obtained from the existing collections noted above with approval, as needed, under exemption
#1197 from the NIH Office of Human Subjects Research. All human samples were, and remain,
anonymized to the investigators at Rocky Mountain Laboratories where the RT-QuIC testing
was performed.
Protein expression and purification
Recombinant prion protein (rPrPSen) substrates were purified as previously described [49].
Briefly, PrP DNA sequences encoding for Syrian golden hamster (residues 23 to 231; accession
no. K02234; or residues 90–231), Bank Vole (residues 23 to 230; Methionine at residue 109;
accession no. AF367624) or hamster-sheep chimera (Syrian hamster residues 23 to 137 fol-
lowed by sheep residues 141 to 234 of the R154Q171 polymorph [accession no. AY907689])
prion protein genes were ligated into the pET41 vector (EMD Biosciences). Vectors were trans-
formed into Rosetta (DE3) Escherichia coli and were grown in Luria broth medium in the pres-
ence of kanamycin and chloramphenicol. Protein expression was induced using the
autoinduction system [50,51] and was purified from inclusion bodies under denaturing condi-
tions using Ni-nitrilotriacetic acid (NTA) superflow resin (Qiagen) with an ÄKTA fast protein
liquid chromatographer (GE Healthcare Life Sciences). The protein was refolded on the col-
umn using a guanidine HCl reduction gradient and eluted using an imidazole gradient as
described [49]. The eluted protein was extensively dialyzed into 10 mM sodium phosphate
buffer (pH 5.8), filtered (0.22-μm syringe filter [Fisher]) and stored at -80°C. Protein concen-
tration was determined by measuring absorbance at 280 nm.
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Brain homogenate preparations
Brain homogenates (BH; 10% w/v, Tables 1 and 2) were prepared as previously described [14]
and stored at -80°C. For RT-QuIC analysis BHs were serially diluted in 0.1% SDS (sodium
dodecyl sulfate, Sigma)/N2 (Gibco)/PBS as previously reported (25), or where indicated the
last dilutions were performed to a final concentration of 0.05% SDS/N2/PBS.
RT-QuIC protocol
RT-QuIC reactions were performed as previously described [14]. Reaction mix was composed
of 10 mM phosphate buffer (pH 7.4), 300 or 130 mMNaCl, 0.1 mg/ml rPrPSen, 10 μM thiofla-
vin T (ThT), 1 mM ethylenediaminetetraacetic acid tetrasodium salt (EDTA), and 0.002% or
0.001% SDS. NaCl and SDS concentrations were varied where indicated. Aliquots of the reac-
tion mix (98 μL) were loaded into each well of a black 96-well plate with a clear bottom (Nunc)
and seeded with 2 μL of indicated BH dilutions. The plate was then sealed with a plate sealer
film (Nalgene Nunc International) and incubated at 42°C in a BMG FLUOstar Omega plate
reader with cycles of 1 min shaking (700 rpm double orbital) and 1 min rest throughout the
indicated incubation time. ThT fluorescence measurements (450 +/-10 nm excitation and 480
+/-10 nm emission; bottom read) were taken every 45 min.
To compensate for minor differences in baselines between fluorescent plate readers and
across multiple experiments, data sets were normalized to a percentage of the maximal fluores-
cence response (260,000 rfu) of the plate readers after subtraction of the baseline, as described
[34], and plotted versus reaction time. Reactions were classified as RT-QuIC positive base on
criteria similar to those previously described for RT-QuIC analyses of brain specimens [14,34].
Proteinase K (PK) digestion of RT-QuIC products and immunoblotting
RT-QuIC reaction products were collected from the plates by extensive scraping and pipetting
and treated with 10 μg/ml Proteinase K (PK) for 1 hour at 37°C with 400 rpm orbital shaking.
Equal volumes of PK-treated reactions were run on 12% Bis-Tris NuPAGE gels (Invitrogen).
Proteins were transferred to an Immobilon P membrane (Millipore) using the iBlot Gel Trans-
fer System (Invitrogen). Membranes were probed with R20 primary antiserum (hamster epi-
tope: residues 218–231) [52] diluted 1:15,000 and visualized with the Attophos AP fluorescent
substrate system (Promega) according to the manufacturer's recommendations.
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